Please check any of the boxes below which best describes the reason for your enquiry:*

I am a family doctor or specialist physician and I would like to offer the EarlyCDT®-Lung test to my patientsI work in a lab and I would like to set up a phlebotomy sample processing agreement for EarlyCDT®-LungI would like to become an independent provider / distributor of the EarlyCDT®-Lung test outside the USI am a specialist respiratory physician and I would like to be listed to receive referrals for the EarlyCDT®-Lung testI am a patient interested in the EarlyCDT®-Lung testI would like to join the mailing list and be kept informed about EarlyCDT® and Oncimmune

I consent to the following uses of personal data by Oncimmune:*
(Please tick at least one of the boxes below)

Passing information to a third party provider of the testReceive future marketing materialContact by phone, post and emailNo consent to any of the above

Oncimmune (USA) LLC

For US Physician and Patient enquiries, including ordering and reimbursement:

Email clientservices@oncimmune.com
Call 1-888-583-9030

Laboratory Address:
8960 Commerce Drive, Building #6
De Soto
KS 66018

Phone: +1 913 583 9000
Fax: +1 913 583 9001

Oncimmune Limited

For non-US enquiries:

Phone: +44 (0)115 8231869

Clinical Sciences Building
Nottingham City Hospital
Hucknall Road

Fax: +44 (0)115 8231958



Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept